The India vaccine market size was valued at INR 129.21 billion in 2025 and is projected to grow at a CAGR of 8.80% during the forecast period of 2026–2035, reaching INR 300.32 billion by 2035. The market is driven by the high burden of infectious diseases, increased focus on local vaccine production, and strategic collaborations between the government, pharmaceutical companies, and international health organizations. With an expanding healthcare infrastructure and growing immunization efforts, India is emerging as a key player in the global vaccine market.Key Drivers of Market Growth
High Burden of Infectious Diseases
India faces a significant burden of infectious diseases, such as tuberculosis, hepatitis, polio, and respiratory infections, which continue to impact the health of its population. The prevalence of vaccine-preventable diseases in the country, particularly among vulnerable groups like children and the elderly, drives the need for increased vaccination coverage. The government’s commitment to improving vaccination rates and addressing public health concerns is propelling the growth of the vaccine market.
Get a Free Sample Report with Table of Contents: Click Here
India's large population and high birth rate further add to the demand for vaccines, particularly for pediatric immunization programs. Vaccines against diseases like measles, diphtheria, tetanus, and influenza continue to be in high demand, contributing to the steady growth of the vaccine market.
Strategic Collaborations and Partnerships
Strategic collaborations between the Indian government, pharmaceutical companies, and global health organizations are also driving the growth of the vaccine market. In recent years, the Indian government has formed partnerships with international organizations, including the World Health Organization (WHO) and the GAVI Alliance, to improve vaccine access and coverage across the country.
Public-private partnerships are facilitating the development and distribution of vaccines, especially in underserved and rural areas, ensuring that immunization efforts reach the broader population. These collaborations are key to enhancing vaccine availability, affordability, and distribution capabilities.
Additionally, India is home to several major vaccine manufacturers that supply vaccines both domestically and to other parts of the world, boosting the country’s position as a global leader in vaccine production and distribution.
Focus on Local Vaccine Production Capabilities
India's growing focus on strengthening its local vaccine production capabilities is another significant factor contributing to the growth of the vaccine market. The country is a major producer of vaccines for both domestic use and export, and it has been investing in increasing its production capacity, particularly for critical vaccines like COVID-19 vaccines, polio vaccines, and others.
The Indian government has actively supported the growth of local vaccine manufacturers, providing subsidies, infrastructure development, and regulatory support. With a robust manufacturing infrastructure, India is positioned to continue growing its vaccine production capabilities, reducing reliance on imported vaccines and ensuring better accessibility to affordable vaccines for its population.